Maskne prevalence and risk factors during the COVID-19 pandemic

Written By :  Dr Manoj Kumar Nayak
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-10-14 18:45 GMT   |   Update On 2022-10-15 05:44 GMT
Advertisement

Maskne prevalence and risk factors during the COVID- 19 pandemic

Onset of COVID-19 pandemic has instilled a habit of use of personal protective equipment (PPE) in the whole world. Mask being an important part of PPE, has become essential for healthcare workers and patients in order to avoid virus transmission. Maskne is a new coined term widely used to describe the form of mechanical acne resulting from the continuous adherence and friction of the mask to the face. Recently an article investigating the prevalence of acne related to prolonged mask wearing in patients attending the outpatient department was published in the Journal of European academy of dermatology and venereology.

Advertisement

A total of 384 patients (272 females and 112 males; median age 26.5) with a diagnosis of mechanical acne due to mask usage attending the dermatology clinic from February 2021 to December 2021were included in the study. Each patient was clinically evaluated and completed a questionnaire regarding the onset of acne, previous history of acne, the personal protective equipment (PPE) exposure, maskne development and the use of contributing factors.

Most patients (70.8%) were females; 64 patients (16.6%) were aged 15–20 years, 232 (60.4%) were aged 21–30 years, 71 (18.5%) were aged 31–40 years and 17 (0.5%) were > 40 years. 129 out of 384 (33.6%) patients reported a previous history of acne and 178 out of 384 (46.3%) had at least a first-degree relative suffering or had suffered of acne. All patients were Caucasians with 76.3% (293/384) reporting the onset of acne since the beginning of mask wearing and the remaining ones 23.7% (91/ 384) described a worsening of acne lesions since the mask usage. The 87.8% of patients included were type I-II Fitzpatrick scale and 12.3% were type III.

The proportion of clinical forms of acne were: 158/384 (41.1%) presented with micro-comedonal lesions, 174/384 (45.3%) presented with papulo-pustular eruptions and 13.6% (52/ 384) presented with nodulo-cystic lesions. Cheeks and chin were the most frequently involved sites. In terms of the degree of severity, 32%, 54% and 14% presented with mild, moderate and severe degree of acne, respectively.

Over half of the patients (74.5%; 286/384) reported the daily use of emollients under the mask and the majority of them worked in closed environments. A statistically significant difference in mean age (P < 0.0001), family history of acne (P < 0.0001) and maskne development [de novo acne (P < 0.01) and acne exacerbation (P < 0.0001)] was assessed between the present study population and the study by Kiely et al.2

Maskne is a facial dermatosis associated to mask use. The continuous use of mask to contain the spread of Covid-19 has caused an increase in maskne incidence. The continuous use of moisturizers can add on to the risk of maskne. The pathogenetic mechanism behind maskne and the therapeutic approach to treat and prevent it is a still mystery.

To conclude a possibility of maskne development should be kept in mind by dermatologists while advising the patients on the general measures to prevent or reduce the side effects of personal protective equipment.

Source-

  1. Villani A, Fabbrocini G, Annunziata MC, Potestio L. Maskne prevalence and risk factors during the COVID-19 pandemic. J Eur Acad Dermatol Venereol. 2022 Sep;36(9):e678-e680.
  2. Kiely LF, O'Connor C, O'Briain G, O'Briain C, Gallagher J, Bourke JF. Maskne prevalence and associated factors in Irish healthcare workers during the COVID-19 pandemic. J Eur Acad Dermatol Venereol 2022; 36:e506–e508.
Tags:    
Article Source : Maskne prevalence and risk factors during the COVID- 19 pandemic

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News